“…These derivatives have been found useful in an extensive range of biological and pharmaceutical actions, including enzyme inhibitors, anticoagulants, antioxidants, antitumor drugs, anti‐diabetic (α‐glucosidase inhibitors) urease inhibitors, anticancers, antibacterials, inhibit c‐Met phosphorylation in BaF 3 /TPR‐Met and EBC‐1 NSCLC cell lines, antimicrobial, antiviral, proliferation inhibition of K‐562 and inhibit HIV‐1 . Recently, several methods have been reported for the synthesis of bis‐coumarin by the reaction of 4‐hydroxycoumarin and various aldehydes in the presence of various homogeneous and heterogeneous catalysts and under various reaction conditions, such as tetrabutylammonium bromide (TBAB), molecular iodine, [bmin] BF 4 , SO 3 H‐functionalized IL, sodium dodecyl sulfate, piperidine, n‐dodecylbenzene sulfonic acid (DBSA), [pyridin‐SO 3 H]Cl, TrBr and [Fe 3 O 4 @SiO 2 @(CH 2 ) 3 ‐Im‐SO 3 H]Cl, MNPs‐PSA and Fe 3 O 4 @SiO 2 @(CH 2 ) 3 semicarbazide‐SO 3 H/HCl . Although all the procedures for the synthesis of corresponding bis‐coumarin have their merits, the main disadvantages of these methods are often tedious work‐up procedures, low yields, harsh reaction conditions, and the use of toxic, corrosive and expensive catalysts, and the recovery of these catalysts are often difficult.…”